Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Biotech
BMS' CAR-T cracks down on lupus, achieving sustained responses
One patient had a grade 3 case of immune effector cell-associated neurotoxicity syndrome, an adverse event associated with CAR-T therapy.
Nick Paul Taylor
Nov 14, 2024 10:00am
Merck pays $588M for bispecific to defend Keytruda’s kingdom
Nov 14, 2024 7:45am
Gubra reveals early data for once-weekly obesity asset
Nov 13, 2024 5:56pm
Adaptimmune's cell therapy hits key goal in pivotal sarcoma test
Nov 13, 2024 2:57pm
Entero and ADC-like biotech Journey pen reverse merger
Nov 13, 2024 10:40am
Syros flunks phase 3 blood cancer trial, triggering loan default
Nov 13, 2024 10:00am
